| FDG Digital PET/CT as First Line Investigation for Giant Cell Arteritis (NCT05000138) | Jewish General Hospital | 2022-06-10 |
| Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases (NCT05251415) | University Hospital, Toulouse | 2022-04-04 |
| National Vaccine Adverse Event Reporting Survey and Etiology (NCT05095844) | Neuroganics LLC | 2022-03-15 |
| SysteMic vAsculitis pRognosis and ouTcome (NCT07586137) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2022-02-08 |
| Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19 (NCT05115370) | University of Nottingham | 2021-11-01 |
| Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. TRIBECA STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated Vasculitis) (NCT04629144) | Assistance Publique - Hôpitaux de Paris | 2021-10-20 |
| A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis (NCT05263817) | Zhejiang University | 2021-10-08 |
| CXCR4-PET/CT for Diagnosing Giant Cell Arteritis (NCT05604482) | Matthias Fröhlich | 2021-10-01 |
| Longitudinal Study for Relapsing Polychondritis (NCT04919538) | University of Pennsylvania | 2021-02-26 |
| Monıtorıng Glucocortıcoıd Treatment In Patıents Followed In Rheumatology Clınıc (NCT05292456) | Hacettepe University | 2021-02-01 |
| Giant Cell Arteritis and Differential Diagnoses Associated With Positive Temporal Artery Biopsy (NCT04554290) | Central Hospital, Nancy, France | 2020-08-01 |
| Vascular Lab Resource (VLR) Biorepository (NCT05628948) | The Cleveland Clinic | 2019-11-14 |
| Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders (NCT02418273) | Indiana University | 2019-08-01 |
| Whole Exome Sequencing of Familial and Pediatric Forms of Vasculitis (NCT04006535) | Benjamin Terrier | 2019-06-01 |
| Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases (NCT03937856) | Johns Hopkins University | 2019-05-07 |
| JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors (NCT04294771) | Groupe Hospitalier Pitie-Salpetriere | 2019-01-01 |
| TransIent Perivascular Inflammation of the Carotid Artery (TIPIC) Syndrome: Clinical and Radiological Follow-up (NCT03804112) | Fondation Ophtalmologique Adolphe de Rothschild | 2018-12-17 |
| Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis (NCT03755245) | Turku University Hospital | 2018-11-23 |
| Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis (NCT03693586) | Hospital General de Mexico | 2018-10-19 |
| Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease (NCT03371095) | Assistance Publique - Hôpitaux de Paris | 2018-05-25 |
| Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in Rheumatology (NCT03459274) | Cedars-Sinai Medical Center | 2018-03-16 |
| Journey of Patients With Vasculitis From First Symptom to Diagnosis (NCT03410290) | University of Pennsylvania | 2018-01-11 |
| Clinical Transcriptomics in Systemic Vasculitis (CUTIS) (NCT03004326) | Peter Merkel | 2017-01-01 |
| Endothelin Antagonism in ANCA Vasculitis (NCT02062346) | University of Edinburgh | 2016-08-01 |
| Vasculitis Pregnancy Registry (NCT02593565) | University of Pennsylvania | 2015-11-01 |
| Interferon-lambda: Novel Biologics for Controlling Neutrophil-mediated Pathology in Rheumatic Diseases? (NCT02498808) | University of Oxford | 2015-09-01 |
| Phenomics in Autoimmune and Inflammatory Diseases (NCT02466217) | Assistance Publique - Hôpitaux de Paris | 2015-07-29 |
| The ANCA Vasculitis Questionnaire (AAV-PRO©) (NCT02507024) | University of Pennsylvania | 2015-07-01 |
| Impact of Vasculitis on Employment and Income (NCT02476292) | University of South Florida | 2015-06-01 |
| Pregnancy and Medically Assisted Conception in Rare Diseases (NCT02450396) | Assistance Publique - Hôpitaux de Paris | 2015-06-01 |
| Evaluation of Ultrasound and PET/CT in the Diagnosis and Monitoring of Giant Cell Arteritis (NCT03765424) | University of Aarhus | 2014-10-01 |
| The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach (NCT01933724) | University of South Florida | 2014-02-17 |
| Direct Antiviral Agents for Hepatitis C Virus-associated Cryoglobulinaemia Vasculitis (NCT02856243) | Assistance Publique - Hôpitaux de Paris | 2013-11-01 |
| Immunogenicity and Safety of Vaccinations in Immunocompromised Persons (NCT01947465) | University of Zurich | 2013-10-01 |
| Belimumab in Remission of VASculitis (NCT01663623) | Human Genome Sciences Inc., a GSK Company | 2013-03-20 |
| PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases (NCT02084147) | Case Comprehensive Cancer Center | 2013-03-07 |
| A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Vasculitis (NCT01363388) | Amgen | 2011-09-01 |
| Alemtuzumab for ANCA Associated Refractory Vasculitis (NCT01405807) | Cambridge University Hospitals NHS Foundation Trust | 2011-02-01 |
| Positron Emission Tomography of Infection and Vasculitis (NCT01878721) | Turku University Hospital | 2011-01-01 |
| Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis (NCT01795456) | The Cleveland Clinic | 2010-08-01 |
| Ilaris® in Urticarial Vasculitis - Investigation of Treatment Responses (NCT01170936) | Charite University, Berlin, Germany | 2010-07-01 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy Participants (NCT05984251) | Amgen | 2009-12-21 |
| National Registry of Rare Kidney Diseases (NCT06065852) | UK Kidney Association | 2009-11-06 |
| The CARRA Registry (NCT01697254) | Duke University | 2009-08-01 |
| Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis (NCT00414128) | Cambridge University Hospitals NHS Foundation Trust | 2007-03-01 |
| The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease (NCT00331331) | National Eye Institute (NEI) | 2007-02-14 |
| Improving the Quality of Patient Care by Using a Clinical Expert System. (NCT00430755) | Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) | 2005-08-01 |
| Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years (NCT00307671) | Assistance Publique - Hôpitaux de Paris | 2005-07-01 |
| Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis (NCT00104299) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-01-01 |
| Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA) (NCT00103792) | University Medical Center Groningen | 2004-12-01 |
| Hematopoietic Stem Cell Support in Vasculitis (NCT00278512) | Northwestern University | 2003-08-01 |
| Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis (NCT00128895) | University Medical Center Groningen | 2003-06-01 |
| MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis (NCT00301652) | Nanjing University School of Medicine | 2003-06-01 |
| Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation (NCT00005928) | National Heart, Lung, and Blood Institute (NHLBI) | 2000-06-01 |
| Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes (NCT00004567) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-02-01 |
| Etanercept to Treat Wegener's Granulomatosis (NCT00001901) | National Institute of Allergy and Infectious Diseases (NIAID) | 1999-02-01 |
| Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions (NCT00001764) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-04-01 |
| Absorption of Corticosteroids in Children With Juvenile Dermatomyositis (NCT00004357) | Northwestern University | 1997-09-01 |
| Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis (NCT00001541) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-04-01 |
| Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides (NCT00001473) | National Institute of Allergy and Infectious Diseases (NIAID) | 1995-03-01 |
| Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity (NCT03941184) | Mayo Clinic | 1995-01-01 |
| Steroids and Methotrexate to Treat Systemic Vasculitis (NCT00001256) | National Institute of Allergy and Infectious Diseases (NIAID) | 1990-03-01 |
| Treatment of Wegener's Granulomatosis With Cyclophosphamide (NCT00001155) | National Institute of Allergy and Infectious Diseases (NIAID) | 1976-02-01 |
| Assessment of Patients With Multiple Sclerosis (MS) (NCT00001156) | National Institute of Neurological Disorders and Stroke (NINDS) | 1976-01-23 |